Anti-atherosclerotic potential of fatty acids in Chlorella vulgaris via inhibiting the foam cell formation: An in silico study
Abstract
Background: WHO in 2019 announced that atherosclerosis is included in the top leading cause of mortality, which is more than 32% of deaths worldwide. The most common early symptom of atherosclerosis is the formation of foam cells inside blood vessel wall. Fatty acids from Chlorella vulgaris have the potential to inhibit foam cell formation. The purpose of this study is to analyze the inhibitory activity of fatty acids from C. vulgaris towards various proteins involved in foam cell formation.
Methods: The fatty acids content of C. vulgaris was determined based on previous research. The molecular samples of fatty acids and proteins including CETP, LOX1, ACAT1, and CD36 were obtained from the PubChem and RCSB PDB databases. Drug-likeness and probable activity screening were conducted using the SWISS ADME and PASS Online web servers. Molecular docking was performed using AutoDock Vina, which is integrated into the PyRx software.
Results: All fatty acids comply with the Lipinski rule of five. Thirteen fatty acids were predicted to have anti-atherosclerosis activity based on PASS online screening: myristoleic acid, hexadecadienoic acid, linolenic acid, palmitoleic acid, linoleic acid, heptadecenoic acid, oleic acid, eicosadienoic acid, nonadecenoic acid, gadoleic acid, heneicosanoic acid, brassidic acid, and nervonic acid. Molecular docking simulation results showed that Nervonic acid binds to CETP, LOX1, and ACAT1 in the same site as an inhibitor with the lowest binding affinity value (-5.9, -7, and -7.8 kcal/mol). Hexadecadienoic acid binds to CD36 with the lowest binding affinity value (-4.9 kcal/mol) and binds in the same site with inhibitor.
Conclusion: Therefore, nervonic acid and hexadecadienoic acid have a high potential as a foam cell formation inhibitor.
Keywords: Atherosclerosis; Fatty acid; Foam cell; Molecular docking
Full Text:
PDFReferences
Chan J, Karere GM, Cox LA, VandeBerg JL, Iughetti BPL, et al. Animal Models of Diet-induced Hypercholesterolemia. Hypercholesterolemia. InTech, (2015).
Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, et al. Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products. Pharmacological Reviews, (2019); 71(4): 596-670.
Gao S, Liu J. Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chronic Diseases and Translational Medicine, (2017); 3(2): 89-94.
Jürgens G, Hoff HF, Chisolm GM, Esterbauer H. Modification of human serum low density lipoprotein by oxidation - Characterization and pathophysiological implications. Chemistry
Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cellular and Molecular Life Sciences, (2013); 70(16): 2859-72.
Yu X-H, Fu Y-C, Zhang D-W, Yin K, Tang C-K. Foam cells in atherosclerosis. Clinica Chimica Acta, (2013); 424: 245-52.
Gupta KK, Ali S, Sanghera RS. Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence. Cardiology and Therapy, (2019); 8(1): 5-20.
Adarme-Vega TC, Lim DKY, Timmins M, Vernen F, Li Y, Schenk PM. Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production. Microbial Cell Factories, (2012); 11(1): 96.
Ali R, El-Anany AM, Almujaydil MS, Alhomaid RM, Alharbi HF, Algheshairy RM et al. Impact of Chlorella vulgaris powder on the nutritional content and preference of Khalas date spread. Frontiers in Nutrition, (2025); 12: 1617754.
Richmond A. Handbook of microalgal culture: biotechnology and applied phycology. Oxford Ames: Blackwell Science, (2004).
Ru ITK, Sung YY, Jusoh M, Wahid MEA, Nagappan T. Chlorella vulgaris?: a perspective on its potential for combining high biomass with high value bioproducts. Applied Phycology, (2020); 1(1): 2-11.
Montone CM, Aita SE, Catani M, Cavaliere C, Cerrato A, Piovesana S, et al. Profiling and quantitative analysis of underivatized fatty acids in Chlorella vulgaris microalgae by liquid chromatography–high resolution mass spectrometry. Journal of Separation Science, (2021); 44(16): 3041-51.
Steinbrecher UP. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. Journal of Biological Chemistry, (1987); 262(8): 3603-8.
Chang CL, Deckelbaum RJ. Omega-3 fatty acids: mechanisms underlying 'protective effects' in atherosclerosis. Current Opinion in Lipidology, (2013); 24(4): 345-50.
Chovančiková M, Šimek V. Effects of high-fat and Chlorella vulgaris feeding on changes in lipid metabolism in mice. Biologia Bratislava, (2001); 56(6): 661-666.
Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling: In silico pharmacology for drug discovery. British
Zloh M, Kirton SB. The benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions. Future Medicinal Chemistry, (2018); 10(4): 423-32.
Orekhov AN, Sobenin IA, Revin VV, Bobryshev YV. Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach. Oxidative Medicine and Cellular Longevity, (2015); 2015: 1-11.
Montone CM, Aita SE, Catani M, Cavaliere C, Cerrato A, Piovesana S, et al. Profiling and quantitative analysis of underivatized fatty acids in Chlorella vulgaris microalgae by liquid chromatography-high resolution mass spectrometry. Journal of Separation Science, (2021); 44(16): 3041-51.
Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, (2017); 7: 1-13.
Widyananda MH, Muflikhah L, Ulfa SM, Widodo N. Unveiling the antibreast cancer mechanism of Euphorbia hirta ethanol extract: computational and experimental study. Journal of Biologically Active Products from Nature, (2024); 14(3): 359-82.
Dallakyan S, Olson AJ. Small Molecule Library Screening by Docking with PyRx, (2015).
Widyananda MH, Wicaksono ST, Rahmawati K, Puspitarini S, Ulfa SM, Jatmiko YD, et al. A Potential Anticancer Mechanism of Finger Root (Boesenbergia rotunda) Extracts against a Breast Cancer Cell Line. Scientifica, (2022); 2022: 1-17.
Widyananda MH, Pratama SK, Samoedra RS, Sari FN, Ansori ANM, Antonius Y. Molecular docking study of sea urchin (Arbacia lixula) peptides as multi-target inhibitor for non-small cell lung cancer (NSCLC) associated proteins. Journal of Pharmacy & Pharmacognosy Research, (2021); 9(4): 484-96.
Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, (2009); 31(2): 455-461
Kumar N, Sood D, Tomar R, Chandra R. Antimicrobial Peptide Designing and Optimization Employing Large-Scale Flexibility Analysis of Protein-Peptide Fragments. ACS Omega, (2019); 4(25): 21370-80.
Hammoudi N-E-H, Sobhi W, Attoui A, Lemaoui T, Erto A, Benguerba Y. In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug-likeness evaluation. Journal of Molecular Structure, (2021); 1229: 129845.
Benet LZ, Hosey CM, Ursu O, Oprea TI, Sciences T, Division I. HHS Public Access. Advanced Drug Delivery Reviews, 2017; 101: 89-98.
Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskii DS, Pogodin PV, et al. Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource. Chemistry of Heterocyclic Compounds, (2014); 50(3): 444-57.
Djoussé L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis: the National Heart, Lung, and Blood Institute Family Heart Study. The American Journal of Clinical Nutrition, (2003); 77(4): 819-25.
Rencüzoğullari I, Karabağ Y, Cağdaş M, Adali Y, Karakoyun S, et al. Impact of supplementation with branched chain amino acids on myocardium and coronary in regularly and intensively exercising rats. Kafkas Universitesi Veteriner Fakultesi Dergisi. (2018); 24(3): 459-466.
Sato M, Shibata K, Nomura R, Kawamoto D, Nagamine R, Imaizumi K. Linoleic acid-rich fats reduce atherosclerosis development beyond its oxidative and inflammatory stress-increasing effect in apolipoprotein E-deficient mice in comparison with saturated fatty acid-rich fats. British Journal of Nutrition, (2005); 94(6): 896-901.
Zhang M, Charles R, Tong H, Zhang L, Patel M, Wang F, et al. HDL surface lipids mediate CETP binding as revealed by electron microscopy and molecular dynamics simulation. Scientific Report, (2015); 5(1): 8741.
Barter PJ, Rye K-A. Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead-Pro. Arteriosclerosis, thrombosis, and vascular biology, (2016); 36(3): 439-41.
Chapman MJ, Orsoni A, Robillard P, Therond P, Giral P. Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP. Journal of Clinical Lipidology, (2018); 12(3): 784-800.e4.
Ganesan R, Henkels KM, Wrenshall LE, Kanaho Y, Di Paolo G, Frohman MA, et al. Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence. Journal of Leukocyte Biology, (2018); 103(5): 867-83.
Kattoor AJ, Goel A, Mehta JL. LOX-1: Regulation, Signaling and Its Role in Atherosclerosis. Antioxidants, (2019); 8(7): 218.
Park H, Adsit FG, Boyington JC. The 1.4 Å Crystal Structure of the Human Oxidized Low Density Lipoprotein Receptor Lox-1. Journal of Biological Chemistry, (2005); 280(14): 13593-9.
Stein S, Lohmann C, Schäfer N, Hofmann J, Rohrer L, Besler C, et al. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. European Heart Journal, (2010); 31(18): 2301-9.
Schnapp G, Neubauer H, Büttner FH, Handschuh S, Lingard I, Heilker R, et al. A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state. Communications Chemistry, (2020); 3(1): 75.
Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metabolism, (2006); 4(3): 211-21.
Pepino MY, Kuda O, Samovski D, Abumrad NA. Structure-Function of CD36 and Importance of Fatty Acid Signal Transduction in Fat Metabolism. Annual Review of Nutrition, (2014); 34(1): 281-303.
Vazquez MM, Gutierrez MV, Salvatore SR, Puiatti M, Dato VA, Chiabrando GA, et al. Nitro-oleic acid, a ligand of CD36, reduces cholesterol accumulation by modulating oxidized-LDL uptake and cholesterol efflux in RAW2647 macrophages. Redox Biology, (2020); 36: 101591.
Cho KH, An S, Lee WS, Paik YK, Kim YK, Jeong TS. Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: A different substrate specificity and inhibitory regulation. Biochemical and Biophysical Research Communications, (2003); 309(4): 864-72.
Dove DE, Su YR, Swift LL, Linton MF, Fazio S. ACAT1 deficiency increases cholesterol synthesis in mouse peritoneal macrophages. Atherosclerosis, (2006); 186(2): 267-74.
Rogers MA, Liu J, Song BL, Li BL, Chang CCY, Chang TY. Acyl-CoA:cholesterol acyltransferases (ACATs/SOATs): Enzymes with multiple sterols as substrates and as activators. The Journal of Steroid Biochemistry and Molecular Biology, (2015); 151: 102-7.
Yang L, Yang JB, Chen J, Yu GY, Zhou P, Lei L, et al. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone. Cell Research, (2004); 14(4): 315-23.
Ohmoto T, Nishitsuji K, Yoshitani N, Mizuguchi M, Yanagisawa Y, Saito H, et al. K604, a specific acyl-CoA:cholesterol acyltransferase 1 inhibitor, suppresses proliferation of U251-MG glioblastoma cells. Molecular Medicine Reports, (2015); 12(4): 6037-42.
DOI: http://dx.doi.org/10.62940/als.v12i2.3182
Refbacks
- There are currently no refbacks.